Human Gene Therapy : Impact Factor & More
eISSN: 1557-7422pISSN: 1043-0342
Share this on:
Key Metrics
CiteScore 
8.2
Eigenfactor
0.005 - 0.01
H-Index
156
Impact Factor
< 5
SJR
Q2Genetics
SNIP
1.05
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Human Gene Therapy
Human Gene Therapy Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1990 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Human Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Human Gene Therapy
Safety, Tolerability, and Efficacy of a Prophylactic Sirolimus Protocol for Patients Receiving Delandistrogene Moxeparvovec-Rokl Gene Therapy.
- 5 Aug 2026
- Human gene therapy
Suppression of AAV-Delivered Transgene Expression Using Artificial MicroRNAs Delivered by an Alternative AAV Serotype.
- 5 Aug 2026
- Human gene therapy
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.
- 3 Aug 2026
- Human gene therapy
Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors.
- 3 Aug 2026
- Human gene therapy
Adeno-Associated Virus-Mediated Central Nervous System Gene Transfer to Suppress Alzheimer's Disease High-Risk APOE4 Variant and Replace with Protective APOE2.
- 2 Aug 2026
- Human gene therapy
Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects.
- 1 Aug 2026
- Human gene therapy
Safety, Tolerability, and Efficacy of a Prophylactic Sirolimus Protocol for Patients Receiving Delandistrogene Moxeparvovec-Rokl Gene Therapy.
- 5 Aug 2026
- Human gene therapy
Suppression of AAV-Delivered Transgene Expression Using Artificial MicroRNAs Delivered by an Alternative AAV Serotype.
- 5 Aug 2026
- Human gene therapy
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.
- 3 Aug 2026
- Human gene therapy
Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors.
- 3 Aug 2026
- Human gene therapy
Adeno-Associated Virus-Mediated Central Nervous System Gene Transfer to Suppress Alzheimer's Disease High-Risk APOE4 Variant and Replace with Protective APOE2.
- 2 Aug 2026
- Human gene therapy
Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects.
- 1 Aug 2026
- Human gene therapy
FAQs on Human Gene Therapy
How long has Human Gene Therapy been actively publishing? 
What is the publishing frequency of Human Gene Therapy?
How many articles did Human Gene Therapy publish last year?
What is the eISSN & pISSN for Human Gene Therapy?
What is Citescore for Human Gene Therapy?
What is the H Index for Human Gene Therapy ?
What is SNIP score for Human Gene Therapy?
What is the SJR for Human Gene Therapy?
Who is the publisher of Human Gene Therapy?
